Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00499785 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2017-05-30
Summary
RATIONALE: Learning about physical ability and mental function over time in older patients with acute myeloid leukemia may help doctors learn about the long-term effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is assessing physical and mental status in older patients with newly diagnosed acute myeloid leukemia.
Conditions
- Cognitive/Functional Effects
- Depression
- Leukemia
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Heidi D. Klepin, MD · Wake Forest University Health Sciences
-
Bayard L. Powell, MD · Wake Forest University Health Sciences
Eligibility
- Min Age
- 60 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2009-01-31
- Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)
NCT02662920 ·Status: COMPLETED
-
Quality of Life Model for Older Patients With AML
NCT04380441 ·Status: ACTIVE_NOT_RECRUITING
-
Psychological Intervention Mobile App for Patients With AML
NCT03372291 ·Status: COMPLETED ·Phase: NA
-
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT00459524 ·Status: COMPLETED
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Psychological Mobile App for Patients With AML
NCT05501171 ·Status: TERMINATED ·Phase: NA
-
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
NCT04920188 ·Status: TERMINATED
-
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
NCT01321385 ·Status: COMPLETED
-
Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia
NCT01498302 ·Status: COMPLETED
-
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00003790 ·Status: COMPLETED
-
Frequency and Risk Factors of Acute Myeloid Leukemia
NCT05787951 ·Status: UNKNOWN
-
Novel Digital Application for Patients With Acute Leukemia
NCT06472128 ·Status: RECRUITING ·Phase: NA
-
Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia
NCT04885127 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
NCT01385150 ·Status: COMPLETED
-
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
NCT03728699 ·Status: COMPLETED
-
A Telehealth Advance Care Planning Intervention
NCT05875805 ·Status: RECRUITING ·Phase: NA
-
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT04745676 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
NCT00049517 ·Status: COMPLETED ·Phase: PHASE3
-
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
NCT05335369 ·Status: COMPLETED ·Phase: NA
-
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
NCT03422731 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia
NCT01024127 ·Status: COMPLETED
-
High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00002865 ·Status: COMPLETED ·Phase: PHASE2
-
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
NCT02038153 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
NCT00002531 ·Status: UNKNOWN ·Phase: PHASE2